Cargando…
838. Oral Vancomycin Prophylaxis Works!
BACKGROUND: Clostridium difficile infections (CDI) cause approximately 500,000 cases a year with an estimated cost that exceeds $4.8 billion. Despite interventions that addressed environmental disinfection, antibiotic stewardship, and infection control, many institutions continue to have a significa...
Autores principales: | Van Hise, Nicholas W, Hines, David, Didwania, Vishal, Beezhold, David, Chundi, Vishnu, Fliegelman, Robert, Han, Alice, Van Hise, Allyssa, Chundi, Vaishali, Manian, Farrin, Petrak, Russell M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808830/ http://dx.doi.org/10.1093/ofid/ofz359.023 |
Ejemplares similares
-
1420. Successful Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin
por: Van Hise, Nicholas W, et al.
Publicado: (2019) -
Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2
por: Petrak, Russell M., et al.
Publicado: (2021) -
A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
por: Van Hise, Nicholas, et al.
Publicado: (2020) -
Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study
por: Van Hise, Nicholas W., et al.
Publicado: (2020) -
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Petrak, Russell M., et al.
Publicado: (2021)